drug protocol number

A2581186

drug sponsor

Pfizer

drug study

N/A

drug trial site

Dallah Hospital (Riyadh), Al Mana General Hospital (Khobar), University District Hospital (Jeddah), Al Shifa Medical Hospital (Makkah)

drug status

Ongoing

drug phase